{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:59:49Z","timestamp":1790589589059,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>The role of the CYP17A1 gene\u2019s rs743572 polymorphism in cancer susceptibility has been a subject of extensive investigation, yet existing evidence remains inconclusive. In this meta-analysis, we systematically reviewed and synthesized data from 29 studies to assess the CYP17A1 rs743572 polymorphism\u2019s relationship with cancer susceptibility. We strictly searched on EMBASE, PubMed, and Web of Science databases and explored rs743572 polymorphism\u2019s association with cancer risks according to search strategy, enrolling 29 studies (13,767 cases and 17,441 controls). rs743572 was markedly related to enhanced cancer susceptibility risk; FPRP and TSA analyses were employed for confirmation. According to cancer type-based stratified analyses, rs743572 exhibited a notable association with bladder cancer, breast cancer, non-Hodgkin lymphoma, and hepatocellular cancer. In conclusion, systematic meta-analysis suggests a significant role for the rs743572 polymorphism in cancer pathogenesis, with particular prominence observed in bladder cancer, breast cancer, non-Hodgkin lymphoma, and hepatocellular cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0326843","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:28:11Z","timestamp":1750876091000},"page":"e0326843","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between CYP17A1 rs743572 polymorphism and cancer risk: A meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-1074","authenticated-orcid":true,"given":"Bin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhumin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"3","key":"pone.0326843.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0326843.ref002","doi-asserted-by":"crossref","first-page":"110952","DOI":"10.1016\/j.exger.2020.110952","article-title":"The effects of environmental stressors on candidate aging associated genes","volume":"137","author":"M Andrawus","year":"2020","journal-title":"Exp Gerontol"},{"key":"pone.0326843.ref003","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"M Zhao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0326843.ref004","doi-asserted-by":"crossref","first-page":"112085","DOI":"10.1016\/j.jinorgbio.2022.112085","article-title":"Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1)","volume":"240","author":"S-G Lee","year":"2023","journal-title":"J Inorg Biochem"},{"key":"pone.0326843.ref005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.mie.2023.05.010","article-title":"Generation of human steroidogenic cytochrome P450 enzymes for structural and functional characterization","volume":"689","author":"SD Burris-Hiday","year":"2023","journal-title":"Methods Enzymol"},{"issue":"3","key":"pone.0326843.ref006","doi-asserted-by":"crossref","first-page":"102999","DOI":"10.1016\/j.jbc.2023.102999","article-title":"Human cytochrome P450 17A1 structures with metabolites of prostate cancer drug abiraterone reveal substrate-binding plasticity and a second binding site","volume":"299","author":"EM Petrunak","year":"2023","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0326843.ref007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/ddu478","article-title":"Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension","volume":"24","author":"X Lu","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"6","key":"pone.0326843.ref008","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181452","article-title":"TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case-control studies","volume":"38","author":"J Meng","year":"2018","journal-title":"Biosci Rep"},{"key":"pone.0326843.ref009","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1038\/srep06159","article-title":"Association of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: evidence from a meta-analysis","volume":"4","author":"J He","year":"2014","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0326843.ref010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the probability that a positive report is false: an approach for molecular epidemiology studies","volume":"96","author":"S Wacholder","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"pone.0326843.ref011","article-title":"Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population","author":"J He","year":"2013","journal-title":"Mol Carcinog"},{"key":"pone.0326843.ref012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2407-7-123","article-title":"Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk","volume":"7","author":"L Bethke","year":"2007","journal-title":"BMC Cancer"},{"issue":"5","key":"pone.0326843.ref013","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1007\/s13277-013-1594-1","article-title":"Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India","volume":"35","author":"S Chattopadhyay","year":"2014","journal-title":"Tumour Biol"},{"issue":"3","key":"pone.0326843.ref014","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ijc.24792","article-title":"Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California","volume":"126","author":"EJ Duell","year":"2010","journal-title":"Int J Cancer"},{"key":"pone.0326843.ref015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7314\/APJCP.2016.17.S3.23","article-title":"Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer","volume":"17","author":"F Farzaneh","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"pone.0326843.ref016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-069X-13-19","article-title":"Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women","volume":"13","author":"M Ghisari","year":"2014","journal-title":"Environ Health"},{"key":"pone.0326843.ref017","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.envres.2017.01.020","article-title":"Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort","volume":"154","author":"M Ghisari","year":"2017","journal-title":"Environ Res"},{"key":"pone.0326843.ref018","doi-asserted-by":"crossref","first-page":"131880","DOI":"10.1016\/j.chemosphere.2021.131880","article-title":"Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk","volume":"286","author":"H He","year":"2022","journal-title":"Chemosphere"},{"key":"pone.0326843.ref019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7314\/APJCP.2016.17.S3.71","article-title":"Association of the CYP17-34T\/C Polymorphism with Pancreatic Cancer Risk","volume":"17","author":"S Hussain","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"pone.0326843.ref020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/01635580903441279","article-title":"Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians","volume":"62","author":"M Iwasaki","year":"2010","journal-title":"Nutr Cancer"},{"key":"pone.0326843.ref021","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000438940","article-title":"Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer","volume":"38","author":"N Karakus","year":"2015","journal-title":"Oncol Res Treat"},{"key":"pone.0326843.ref022","doi-asserted-by":"crossref","first-page":"138314","DOI":"10.1016\/j.scitotenv.2020.138314","article-title":"Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer","volume":"730","author":"LJ Martinez-Gonzalez","year":"2020","journal-title":"Sci Total Environ"},{"issue":"9","key":"pone.0326843.ref023","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10552-008-9160-7","article-title":"Variants in hormone biosynthesis genes and risk of endometrial cancer","volume":"19","author":"SH Olson","year":"2008","journal-title":"Cancer Causes Control"},{"key":"pone.0326843.ref024","doi-asserted-by":"crossref","first-page":"156965","DOI":"10.1016\/j.scitotenv.2022.156965","article-title":"Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer","volume":"843","author":"D Martin-Way","year":"2022","journal-title":"Sci Total Environ"},{"key":"pone.0326843.ref025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10549-009-0490-2","article-title":"Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism","volume":"120","author":"The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk","year":"2010","journal-title":"Breast Cancer Research Treatment"},{"issue":"5","key":"pone.0326843.ref026","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10552-012-9925-x","article-title":"Estrogen-related genes and their contribution to racial differences in breast cancer risk","volume":"23","author":"KW Reding","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"4","key":"pone.0326843.ref027","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2010.10.003","article-title":"Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers","volume":"35","author":"M Risio","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"pone.0326843.ref028","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1530\/EC-19-0225","article-title":"Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk","volume":"8","author":"P Rizzolo","year":"2019","journal-title":"Endocr Connect"},{"issue":"10","key":"pone.0326843.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185447","article-title":"Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness","volume":"12","author":"I Robles-Fernandez","year":"2017","journal-title":"PLoS One"},{"key":"pone.0326843.ref030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-11-0057","article-title":"Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes","volume":"18","author":"A Rudolph","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"pone.0326843.ref031","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-07-2680","article-title":"Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women","volume":"17","author":"LC Sakoda","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"pone.0326843.ref032","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.2005.05505.x","article-title":"Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma","volume":"129","author":"CF Skibola","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0326843.ref033","doi-asserted-by":"crossref","first-page":"15017866","DOI":"10.4238\/gmr.15017866","article-title":"Relationship between CYP17 gene polymorphisms and risk of prostate cancer","volume":"15","author":"J Song","year":"2016","journal-title":"Genet Mol Res"},{"issue":"2","key":"pone.0326843.ref034","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/carcin\/bgx144","article-title":"Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"39","author":"L Tang","year":"2018","journal-title":"Carcinogenesis"},{"issue":"1","key":"pone.0326843.ref035","first-page":"71","article-title":"CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility","volume":"24","author":"BM T\u00fcz\u00fcner","year":"2010","journal-title":"In Vivo"},{"issue":"36","key":"pone.0326843.ref036","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.3748\/wjg.v23.i36.6674","article-title":"Genetic biomarkers for hepatocellular cancer risk in a caucasian population","volume":"23","author":"E De Mattia","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0326843.ref037","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cllc.2012.04.004","article-title":"Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers","volume":"14","author":"Y Zhang","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"pone.0326843.ref038","first-page":"181","article-title":"Association between CYP17A1, CYB5A polymorphisms and efficacy of abiraterone acetate\/prednisone treatment in castration-resistant prostate cancer patients","volume":"13","author":"X Wu","year":"2020","journal-title":"Pharmgenomics Pers Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:28:23Z","timestamp":1750876103000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326843"}},"subtitle":[],"editor":[{"given":"Charushila Yuvraj","family":"Kadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326843","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}